BRIEF published on 01/14/2026 at 16:57, 9 months 28 days ago RHÖN-KLINIKUM AG Revises 2025 EBITDA Forecast Downward EBITDA Forecast Healthcare Provider Cost Management RHÖN-KLINIKUM AG Financial Year 2025
PRESS RELEASE published on 01/14/2026 at 16:52, 9 months 28 days ago EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft adjusts the EBITDA forecast for financial year 2025 RHÖN-KLINIKUM Aktiengesellschaft adjusts EBITDA forecast for 2025 due to unforeseen business developments. Annual report planned on 26 March 2026 EBITDA Forecast Annual Report Business Developments Financial Year 2025 RHÖN-KLINIKUM Aktiengesellschaft
BRIEF published on 11/06/2025 at 09:05, 1 year ago RHÖN-KLINIKUM AG Reports Robust Q3 2025 Financial Performance Financial Results Revenue Growth Healthcare Sector RHÖN-KLINIKUM AG Germany Hospitals
PRESS RELEASE published on 11/06/2025 at 09:00, 1 year ago RHÖN-KLINIKUM AG closes third quarter of 2025 with solid results RHÖN-KLINIKUM AG reports solid results for Q3 2025 with revenue increase and stable equity ratio. Board focuses on consistent management amidst sector challenges in Germany Revenue Increase Equity Ratio RHÖN-KLINIKUM AG Q3 2025 Hospital Sector
BRIEF published on 08/07/2025 at 09:04, 1 year 3 months ago RHÖN-KLINIKUM AG Reports Stable First Half of 2025 Results Revenue Growth Market Conditions Financial Forecast Healthcare Challenges EBITDA Stability
PRESS RELEASE published on 08/07/2025 at 08:59, 1 year 3 months ago RHÖN-KLINIKUM AG closes first half of 2025 with solid results RHÖN-KLINIKUM AG closes first half of 2025 with solid results including revenue growth and stable EBITDA. Management focuses on sustainable operations despite industry challenges Financial Results EBITDA Revenue Growth Healthcare Sector RHÖN-KLINIKUM AG
BRIEF published on 05/08/2025 at 09:04, 1 year 6 months ago RHÖN-KLINIKUM AG Maintains Steady Performance in Q1 2025 Revenue Growth Future Outlook RHÖN-KLINIKUM AG German Healthcare Q1 2025 Results
PRESS RELEASE published on 05/08/2025 at 08:59, 1 year 6 months ago RHÖN-KLINIKUM AG holds steady course in first quarter of 2025 – outlook confirmed RHÖN-KLINIKUM AG reports steady performance in Q1 2025 with revenue up by 8.3% to EUR 414.7 million. Future outlook confirmed with revenue expected to reach EUR 1.7 billion in 2025 Revenue Healthcare Outlook RHÖN-KLINIKUM AG Q1 2025
BRIEF published on 03/27/2025 at 10:04, 1 year 7 months ago RHÖN-KLINIKUM AG Reports Strong Financial Year Amid Leadership Change Strategic Partnerships Financial Performance Leadership Change Sustainability Targets Healthcare Growth
BRIEF published on 11/07/2024 at 09:04, 2 years ago RHÖN-KLINIKUM AG Shows Steady Progress in Q3 2024 Revenue Growth Healthcare Sector Financial Outlook RHÖN-KLINIKUM AG Q3 2024 Results
Published on 11/11/2026 at 23:05, 16 minutes ago Vox Royalty Reports Q3 2026 Results and Declares Quarterly Dividend
Published on 11/11/2026 at 23:00, 21 minutes ago CCL Industries Announces Appointment of New Director
Published on 11/11/2026 at 22:30, 51 minutes ago 55 North Gold Qualifies for Trading on the OTCQB Venture Market and Launches New Corporate Website
Published on 11/11/2026 at 19:31, 3 hours 50 minutes ago Lion Copper Corp. Completes S-K 1300 Technical Report Summary for Bear Copper Deposit
Published on 11/11/2026 at 16:30, 6 hours 51 minutes ago ShelfieTech Announces Expansion Agreement for Its Next-Generation AI Retail Intelligence Platform
Published on 11/11/2026 at 19:29, 3 hours 52 minutes ago EQS-Adhoc: Allianz SE: Allianz delivers record nine-month result of 14.1 billion euros and raises 2026 outlook
Published on 11/11/2026 at 18:41, 4 hours 40 minutes ago AUSTRIACARD HOLDINGS AG: 9M 2026 Financial Results
Published on 11/10/2026 at 17:31, 1 day 5 hours ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 1 day 9 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 1 day 12 hours ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 1 day 16 hours ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 2 days 4 hours ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
